Pt - 杂志Au - Peris，Marisa Au - López-nuñez，Juan J. Au - Maestre，Ana Au - Jimenez，David Au - Muriel，Alfonso Au - Bikdeli，Behnood Au - Weinberg，IDO Au - Ay，Cihan Au -Mazzolai，Lucia Au - Lorenzo，Alicia Au - Monreal，Manuel Au - ，TI - 癌症患者的临床特征和3个月的患者临床疑似和确认肺栓塞助剂 - 10.1183 / 13993003.02723-2020 DP - 2021年7月1日TA - 欧洲呼吸期刊PG - 2002723 VI - 58 IP - 1 4099 - //www.qdcxjkg.com/content/58/1/2002723.short 4100 - http：//www.qdcxjkg.com / content / 58/1 / 2002723.full SO - EUR RESPIR J2021 JUL 01;58 AB - 背景现有指南表明，与临床疑似和确认的PE的人同样地治疗患有肺栓塞（PE）的癌症患者。但是，这些演示文稿的自然历史尚未彻底进行比较。我们使用来自RIETE（REVERTM Informatizodo De EnvermedadTromboembólica）的数据的数据，以比较活性癌症和偶然的PE与临床疑似的患者的3个月结果并确认PE。主要结果是90天的全导致死亡率。二次结果是体育病人有关的死亡率，症状性体育复发和重大出血。从2012年7月至2019年1月，946例患有临床疑似和证实PE的946例患有临床疑似和证实PE的癌症患者。大多数患者（95％对90％）接受了低分子量的肝素治疗。在前90天，598名患者死亡，其中42例来自PE。偶然PE的患者的均导致死亡率低于怀疑和确认的PE（11％对22％;或0.43,95％CI 0.34-0.54）。 Results were consistent for PE-related mortality (0.3% versus 1.7%; OR 0.18, 95% CI 0.06–0.59). Multivariable analysis confirmed that patients with incidental PE were at lower risk of death (adjusted OR 0.43, 95% CI 0.34–0.56). Overall, 29 (0.9%) patients developed symptomatic PE recurrences, and 122 (3.8%) had major bleeding. There were no significant differences in PE recurrences (OR 0.62, 95% CI 0.25–1.54) or major bleeding (OR 0.78, 95% CI 0.51–1.18).Conclusions Cancer patients with incidental PE had a lower mortality rate than those with clinically suspected and confirmed PE. Further studies are required to validate these findings, and to explore optimal management strategies in these patients.In cancer patients with incidental pulmonary embolism the risk of venous thromboembolism recurrences or major bleeding are similar, with a lower mortality https://bit.ly/36AVqSy